NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

This is what I have been saying. Hiring in such a specialized/niche medical field is not a switch you can flip. It takes at least 6-12 months and not to mention training component, process development, etc. on top of that. Demand on finance and operations side itself will be quite big even if you are scaling from a $5-7M in 2023 to $25-50M annual revenue company for 2024. They simply can not execute/fulfill anywhere close to lower end of those revenues with their current team. Forget about sales, marketing, business development, market access, quality assurance, and other critical business functions required to get there.

Or the other explanation outside partnership/buyout scenario is that they do not expect a significant uptick in sales in 2024 and that they plan to build the team gradually. Perhaps U.K. reimbursement will be limited in some way and that FDA and EU approvals are not expected for another 12-18 months. And this may be why big pharma is not interested in NWBO at this time and are taking a wait and watch approach for the next couple of years. This will be the worst case scenario for shareholders.